Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300353
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,564
Award facts
- Contract value 100% obligated
- $6,563.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment headquartered in Walkersville, Maryland, received a $6,563.76 firm fixed-price contract award from the Office of the Director (civilian agency) on June 13, 2013. This was a Blanket Purchase Agreement (BPA) call with no set-aside designation, reflecting open competition. The contract, which ultimatelycompleted on December 31, 2013, supported the procurement of drugs and biologicals for federal research purposes. Lonza Walkersville holds a significantly larger underlying BPA vehicle with the Department of Health and Human Services (HHS) Office of Logistics and Acquisition Operations valued at $10 million through December 31, 2025, which enables streamlined acquisition of biological materials, blood products, media products, and related laboratory supplies and scientific equipment.
As a subsidiary of the global Lonza Group and a registered SAM.gov vendor since 2002, Lonza Walkersville has established itself as a critical supplier to multiple federal research institutions, particularly the National Institutes of Health (NIH) and its constituent institutes. The company specializes in high-precision biological research products including cell culture media, specialized cell lines, and transfection devices that support research initiatives in cancer studies, infectious diseases, regenerative medicine, and cellular engineering. Individual task orders under the larger HHS BPA have historically ranged from approximately $10,000 to $24,000, demonstrating the company's role in supporting complex scientific research infrastructure across federal biomedical research agencies.
Quick answers
Who was awarded contract HHSN26300353?
HHSN26300353 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on June 13, 2013.
How much is contract HHSN26300353 worth?
The government has obligated $6,564 on HHSN26300353.
Is contract HHSN26300353 an order under another contract?
Yes. HHSN26300353 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300353 competed?
The extent of competition for HHSN26300353 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award